Prospective multicenter study finds 46.4% eight-week hemoglobin response to Zaizao Shengxue capsule
A prospective multicenter observational study found that 46.4% of 440 analyzed patients responded to eight weeks of Zaizao Shengxue capsule, ...
A prospective multicenter observational study found that 46.4% of 440 analyzed patients responded to eight weeks of Zaizao Shengxue capsule, ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.